Immune responses in calves immunised orally or subcutaneously with a live Salmonella typhimurium aro vaccine

Vaccine

Volumn 16, Issue 1, 1998, Pages 45-54

  Villarreal Ramos, Bernardo ^a   Manser, Jacqueline ^a   Collins, Robert A ^a   Dougan, Gordon ^b   Chatfield, Steve N ^b   Howard, Christopher J ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cattle; Salmonella; Vaccines

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; RECOMBINANT VACCINE; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CATTLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOBLOTTING; INOCULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTECTION; SALMONELLA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CATTLE; INJECTIONS, SUBCUTANEOUS; LEUKOCYTES; MALE; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; TYPHOID-PARATYPHOID VACCINES; VACCINES, ATTENUATED;

EID: 0031986359     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00156-4     Document Type: Article

References (31)

1. PHLS. Salmonella infections, England and Wales: reports to the PHLS (salmonella data set). Public Health Laboratory Service, Communicable diseases report weekly, 6, 9 Feb 1996.
2. Fleetwood, A., Salmonella in animal and poultry production 1994, Ministry of Agriculture, Food, and Fisheries, 1995.
3. Angerman C.R., Eisenstein T.K. Correlation of the duration and magnitude of protection against Salmonella infection afforded by various vaccines with antibody titers. Infect. Immun. 27:1980;435-443.
4. Germainer R. Immunity in experimental salmonellosis. III. Comparative immunization with viable and heat-inactivated cells of Salmonella typhimurium. Infect. Immun. 5:1972;792-797.
5. Mastroeni P., Villarreal-Ramos B., Hormaeche C.E. Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Infect. Immun. 61:1993;3981-3984.
6. Jones P.W., Collins P., Brown G.T.H., Aitken M.M. Salmonella saint-paul infection in two dairy farms. J. Hyg. Camb. 91:1983;243-257.
7. Jones P.W., Dougan G., Hayward C., Mackensie N., Collins P., Chatfield S.N. Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium. Vaccine. 9:1991;29-34.
8. Robertsson J.A., Lindberg A.A., Hoiseth S., Stocker B.A.D. Salmonella typhimurium infection in calves: Protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines. Infect. Immun. 41:1983;742-750.
9. Segall T., Lindberg A.A. Oral vaccination of calves with an aromatic-dependent Salmonella dublin (O9,12) hybrid expressing O4,12 protects against S. dublin (O9,12) but not against Salmonella typhimurium (O4, 5,12). Infect. Immun. 61:1993;1222-1231.
10. Smith B.P., Reina-Guerra M., Hoiseth S.K., Stocker B.A.D., Habasha F., Johnson E., Merrit F. Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves. Am. J. Vet. Res. 45:1984;59-66.
11. Smith B.P., Dillings G.W., Roden L.D., Stocker B.A.D. Vaccination of calves with orally administered aromatic-dependent Salmonella dublin. Am. J. Vet. Res. 54:1993;1249-1255.
12. Smith B.P., Reina-Guerra M., Stocker B.A.D., Hoiseth S.K., Johnson E. Aromatic-dependent Salmonella dublin as a parenteral modified live vaccine for calves. Am. J. Vet. Res. 45:1984;2231-2235.
13. Hormaeche, C.E., Khan, C.M.A., Mastroeni, P., Villarreal, B., Dougan, G., Roberts, M. and Chatfield, S.N. Salmonella vaccines: mechanisms of immunity and their use as carriers of recombinant antigens. In Molecular and clinical aspects of bacterial vaccine development, ed. D.A.A. Ala'Aldeen and C.E. Hormaeche, John Wiley and Sons Ltd, 1995, pp. 119-153.
14. Oxer M.D., Bentley C.M., Doyle J.G., Peakman T.C., Charles I.G., Makoff A.J. High level heterologous expression in E. coli using the anaerobically-activated nirB promoter. Nucleic Acid Res. 19:1991;2889-2892.
15. Khan C.M.A., Villarreal-Ramos B., Pierce R.J., Riveau G., Hormaeche R.D.d., McNeill H., Ali T., Fairweather N., Chatfield S., Capron A., Dougan G., Hormaeche C.E. Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc. Natl. Acad. Sci. USA. 91:1994;11261-11265.
16. Khan C.M.A., Villarreal-Ramos B., Pierce R.J., Demarco de Hormaeche R., McNeill H., Ali T., Chatfield S., Capron A., Dougan G., Hormaeche C.E. Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115-131 of the P28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live aro-attenuated vaccine strain of Salmonella. J. Immunol. 153:1994;5634-5642.
17. Rappaport F., Konforti N., Navon B. A new enrichment medium for certain Salmonellae. J. Clin. Pathol. 9:1956;261-266.
18. Williams D.J.L., Newson J., Naessens J. Quantitation of bovine immunoglobulin isotypes and allotypes using monoclonal antibodies. Vet. Immunol. Immunopathol. 24:1990;267-283.
19. Demarco de Hormaeche R., Jessop H., Senior K. Gonococcal variants selected by growth in vivo or in vitro have antigenically different LPS. Microb. Path. 4:1988;289-297.
20. Laemli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-683.
21. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedures and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
22. Mishell, B.B., Shiigi, S.M., Henry, C., Chan, E.L., North, J., Gallily, R., Slomich, M., Miller, K., Marbrook, J., Parks, D. and Good, A.H. Preparation of mouse cell suspensions. In Selected methods in cellular immunology, ed. Barbara B. Mishell and Stanley M. Shiigi, W.H. Freeman and company, 1980, pp. 3-27.
23. Villarreal B., Mastroeni P., Demarco de Hormaeche R., Hormaeche C. Proliferative and T-cell specific interleukin (IL-2/IL-4) production responses in spleen cells from mice vaccinated with aroA live attenuated Salmonella vaccines. Microb. Pathol. 13:1992;305-315.
24. Howard C.J., Parsons K.R., Jones B.V., Sopp P., Pocock D.H. Two monoclonal antibodies (CC17, CC29) recognizing an antigen (Bo5) on bovine T lymphocytes, analogous to human CD5. Vet. Immunol. Immunopathol. 19:1988;127-139.
25. Rankin J.D., Taylor R.J. The estimation of doses of Salmonella typhimurium suitable for the experimental production of disease in calves. Vet. Rec. 78:1966;706-707.
26. Lindberg A.A., Andersson J.A. Salmonella typhimurium infection in calves: Cell-mediated and humoral immune reactions before and after challenge with live virulent bacteria in calves given live or inactivated vaccines. Infect. Immun. 41:1983;751-757.
27. Roden L.D., Smith B.P., Spier S.J., Dillings G.W. Effect of calf age and Salmonella bacterin type on ability to produce immunoglobulins directed against Salmonella whole cells or lipopolysacharide. Am. J. Vet. Res. 53:1992;1895-1899.
28. Chatfield S.N., Charles I.G., Makoff A.J., Oxer M.D., Dougan G., Pickard D., Slater D., Fairweather N.F. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single oral dose tetanus vaccine. Biotechnology. 10:1992;888-892.
29. Howard C.J., Clarke M.C., Brownlie J. Protection against respiratory infection with bovine virus diarrhoea virus by passively acquired antibody. Vet. Microbiol. 19:1989;195-203.
30. + T lymphocytes are stimulated to proliferate by autologous Theileria annulata-infected cells in the presence of interleukin-2. Scand. J. Immunol. 44:1996;444-452.
31. Croft M., Carter L., Swain S.L., Dutton R.W. Generation of polarized antigen- specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profile. J. Exp. Med. 180:1994;1715-1728.